Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Liver damage and sickle cell disease: genotype relationship.
Bortolotti M, D'Ambrosio R, Fraquelli M, Pedrotti P, Consonni D, Migone De Amicis M, Scaramellini N, Di Pierro E, Graziadei G. Bortolotti M, et al. Among authors: migone de amicis m. Ann Hematol. 2020 Sep;99(9):2065-2072. doi: 10.1007/s00277-020-04113-3. Epub 2020 Jun 22. Ann Hematol. 2020. PMID: 32572524
Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy.
Motta I, Marcon A, Carrabba MD, Cassinerio E, Migone De Amicis M, Branchi A, Giuditta M, Maira D, Fabio G, Graziadei G, Baldini M. Motta I, et al. Among authors: migone de amicis m. Ann Hematol. 2021 Aug;100(8):2129-2131. doi: 10.1007/s00277-021-04442-x. Epub 2021 Feb 2. Ann Hematol. 2021. PMID: 33528610 Free PMC article. No abstract available.
A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β+-Thalassaemia Patient.
Bortolotti M, Costamagna G, Gagliardi D, Migone De Amicis M, Bresolin N, Graziadei G. Bortolotti M, et al. Among authors: migone de amicis m. Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022019. doi: 10.4084/MJHID.2022.019. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 35444771 Free PMC article. No abstract available.
SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience.
Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, Gianesin B, Graziadei G, Cappellini MD, De Franceschi L, Piga A, Forni GL. Motta I, et al. Among authors: migone de amicis m. Am J Hematol. 2020 Aug;95(8):E198-E199. doi: 10.1002/ajh.25840. Epub 2020 May 6. Am J Hematol. 2020. PMID: 32311145 Free PMC article. No abstract available.
Clostridium difficile infection epidemiology and management: Comparison of results of a prospective study with a retrospective one in a reference teaching and research hospital in Northern Italy.
Domeniconi G, Serafino S, Migone De Amicis M, Formica S, Lanzoni M, Maraschini A, Sisto F, Consonni D, Cappellini MD, Fabio G, Castaldi S. Domeniconi G, et al. Among authors: migone de amicis m. Am J Infect Control. 2016 Nov 1;44(11):1214-1218. doi: 10.1016/j.ajic.2016.05.003. Epub 2016 Jun 29. Am J Infect Control. 2016. PMID: 27372227
Clinical outcomes of Clostridium difficile infection according to strain type. A prospective study in medical wards.
Serafino S, Consonni D, Migone De Amicis M, Sisto F, Domeniconi G, Formica S, Zarantonello M, Maraschini A, Cappellini MD, Spigaglia P, Barbanti F, Castaldi S, Fabio G. Serafino S, et al. Among authors: migone de amicis m. Eur J Intern Med. 2018 Aug;54:21-26. doi: 10.1016/j.ejim.2018.03.015. Epub 2018 Apr 9. Eur J Intern Med. 2018. PMID: 29650357
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial.
Taher AT, Cappellini MD, Kattamis A, Voskaridou E, Perrotta S, Piga AG, Filosa A, Porter JB, Coates TD, Forni GL, Thompson AA, Tartaglione I, Musallam KM, Backstrom JT, Esposito O, Giuseppi AC, Kuo WL, Miteva D, Lord-Bessen J, Yucel A, Zinger T, Shetty JK, Viprakasit V; BEYOND Investigators. Taher AT, et al. Lancet Haematol. 2022 Oct;9(10):e733-e744. doi: 10.1016/S2352-3026(22)00208-3. Epub 2022 Aug 22. Lancet Haematol. 2022. PMID: 36007538 Clinical Trial.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
21 results